
Opinion|Videos|November 29, 2024
Safety of Advanced Therapies in Clinical Trials vs Real World Experience
Key Takeaways
Lisa J. Faia, MD asks the panel about their concerns regarding the safety of newer agents for the broad array of retinal vascular diseases, highlighting the similarities and differences between clinical trial outcomes and real-world results.
Advertisement
Episodes in this series

Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Rayner announces Sophi Phaco System in the US
2
Ophthalmology pipeline watch: Key trial results and PDUFA dates for Q1 2026
3
Ocugen releases positive preliminary 12-month data from phase 2 ArMaDa trial
4
PRIMA retinal implant restores vision in patients with advanced GA
5















































